A comparison of customised and prefabricated insoles to reduce risk factors for neuropathic diabetic foot ulceration: a participant-blinded randomised controlled trial

Joanne S Paton, Elizabeth A Stenhouse, Graham Bruce, Daniel Zahra, Ray B Jones, Joanne S Paton, Elizabeth A Stenhouse, Graham Bruce, Daniel Zahra, Ray B Jones

Abstract

Background: Neuropathic diabetic foot ulceration may be prevented if the mechanical stress transmitted to the plantar tissues is reduced. Insole therapy is one practical method commonly used to reduce plantar loads and ulceration risk. The type of insole best suited to achieve this is unknown. This trial compared custom-made functional insoles with prefabricated insoles to reduce risk factors for ulceration of neuropathic diabetic feet.

Method: A participant-blinded randomised controlled trial recruited 119 neuropathic participants with diabetes who were randomly allocated to custom-made functional or prefabricated insoles. Data were collected at issue and six month follow-up using the F-scan in-shoe pressure measurement system. Primary outcomes were: peak pressure, forefoot pressure time integral, total contact area, forefoot rate of load, duration of load as a percentage of stance. Secondary outcomes were patient perceived foot health (Bristol Foot Score), quality of life (Audit of Diabetes Dependent Quality of Life). We also assessed cost of supply and fitting. Analysis was by intention-to-treat.

Results: There were no differences between insoles in peak pressure, or three of the other four kinetic measures. The custom-made functional insole was slightly more effective than the prefabricated insole in reducing forefoot pressure time integral at issue (27% vs. 22%), remained more effective at six month follow-up (30% vs. 24%, p=0.001), but was more expensive (UK £656 vs. £554, p<0.001). Full compliance (minimum wear 7 hours a day 7 days per week) was reported by 40% of participants and 76% of participants reported a minimum wear of 5 hours a day 5 days per week. There was no difference in patient perception between insoles.

Conclusion: The custom-made insoles are more expensive than prefabricated insoles evaluated in this trial and no better in reducing peak pressure. We recommend that where clinically appropriate, the more cost effective prefabricated insole should be considered for use by patients with diabetes and neuropathy.

Trial registration: Clinical trials.gov (NCT00999635). Note: this trial was registered on completion.

Figures

Figure 1
Figure 1
Example of the insoles used within the trial.
Figure 2
Figure 2
Participants journey through the trial.

References

    1. Armstrong D, Peters E, Athanasiou K, Lavery L. Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration? J Foot Ankle Surg. 1998;37(4):303–307. doi: 10.1016/S1067-2516(98)80066-5.
    1. Frykberg R, Lavery L, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21(10):1714–1719. doi: 10.2337/diacare.21.10.1714.
    1. Lavery L, Armstrong D, Wunderlich R, Tredwel J, Boulton A. Predictive value of foot pressure assessment as part of a population based diabetes disease management program. Diabetes Care. 2003;26(4):1069–1073. doi: 10.2337/diacare.26.4.1069.
    1. Spencer S. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Database Syst Rev. 2000;3:CD002302. doi: 10.1002/14651858.CD002302.
    1. Pitei D, Lord M, Forster A, Wilson S, Watkins P, Edmonds M. Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot. Diabetes Care. 1999;22(12):1966–1970. doi: 10.2337/diacare.22.12.1966.
    1. Grimm A, Kastenbauer T, Sauseng S, Sokol S, Irsigler K. Progression and distribution of plantar pressure in type 2 diabetic patients. Diabetes Nutr Metab. 2004;17(2):108–113.
    1. Maciejewski M, Reiber G, Smith D, Wallace C, Hayes S, Boyko E. Effectiveness of diabetic therapeutic footwear in preventing reulceration. Diabetes Care. 2004;27(7):1774–1782. doi: 10.2337/diacare.27.7.1774.
    1. Bus SA, Ulbrecht JS, Cavanagh PR. Pressure relief and load redistribution by custom-made insoles in diabetic patients with neuropathy and foot deformity. Clin Biomech (Bristol, Avon) 2004;19(6):629–638. doi: 10.1016/j.clinbiomech.2004.02.010.
    1. Mueller M, Hastings M, Commean P, Smith K, Pilgram T, Robertson D, Johnson J. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36(7):1009–1017. doi: 10.1016/S0021-9290(03)00078-2.
    1. Morag E, Cavanagh P. Structural and functional predictors of regional peak pressures under the foot during walking. J Biomech. 1999;32:359–370. doi: 10.1016/S0021-9290(98)00188-2.
    1. Paton J, Woodrow T, Passmore C. The effect of plantar cover padding with U'd cut-out on plantar foot pressure: preliminary study. Brit J Podiatry. 2007;10(3):110–115.
    1. Paton J, Stenhouse E, Jones R, Bruce G. Custom-made total contact insoles and prefabricated functional diabetic insoles: A case report. Diabet Foot J. 2007;10(3):139–142.
    1. Barnett S. The clinical effectiveness of orthoses prescribed to control and reduce diabetic foot pathology. University of the West of England: PhD Thesis; 2002.
    1. Perkins B, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetic clinic. Diabetes Care. 2001;24(2):250–256. doi: 10.2337/diacare.24.2.250.
    1. Paton J, Jones R, Stenhouse E, Bruce G. The physical characteristics of orthotic materials used in the manufacture of orthosis for patients with diabetes. Foot Ankle Int. 2007;20(10):1057–1063.
    1. Hsiao H, Guan J, Weatherly M. Accuracy and precision of two inshoe pressure measurement systems. Ergonomics. 2002;45(8):537–555. doi: 10.1080/00140130210136963.
    1. Mueller M, Strube M. Generalizability of in-shoe peak pressure measures using the F-scan system. Clin Biomech (Bristol, Avon) 1996;11(3):159–164. doi: 10.1016/0268-0033(95)00047-X.
    1. Barnett S, Campbell R, Harvey I. The Bristol Foot Score: Developing a patient-based foot-health measure. J Am Podiatr Med Assoc. 2005;95(3):264–272.
    1. Bradley C, Todd C, Gorton T, Symonds E, Martin A. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQOL. Qual Life Res. 1999;8:79–91.
    1. Keijers N, Stolwijk N, Pataky T. Linear dependence of peak mean and pressure–time integral values in plantar pressure images. Gait Posture. 2010;31:140–142. doi: 10.1016/j.gaitpost.2009.08.248.
    1. Waaijman R, Bus S. The interdependency of peak pressure and pressure–time integral in pressure studies on diabetic footwear: no need to report both parameters. Gait Posture. 2012;35:1–5. doi: 10.1016/j.gaitpost.2011.07.006.
    1. Mohamed O, Cerny K, Rojek L, Herbert K, Turner R, Waistell S. The effects of Plastazote® and Aliplast®/Plastazote® orthoses on plantar pressures in elderly persons with diabetic neuropathy. J Prosthet Orthot. 2004;16(2):55–65. doi: 10.1097/00008526-200404000-00005.
    1. Lobmann R, Kayser R, Kasten G, Kasten U, Kluge K, Neumann W, Lehnert H. Effects of preventative footwear on foot pressure as determined by pedobarography in diabetic patients: a prospective study. Diabet Med. 2001;18(4):314–319. doi: 10.1046/j.1464-5491.2001.00482.x.
    1. Raspovic A, Newcombe L, Lloyd J, Dalton E. Effect of customized insoles on vertical plantar pressures in sites of previous neuropathic ulceration in the diabetic foot. Foot. 2000;10(3):133–138. doi: 10.1054/foot.2000.0604.
    1. Albert S, Rinoie C. Effect of custom orthotics on plantar pressure distribution in the pronated diabetic foot. J Foot Ankle Surg. 1994;33(6):598–604.
    1. Sauseng S, Kastenbauer T, Sokol S, Irsigler K. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy. Diabetes Nutr Metab. 1999;12:189–193.
    1. Armstrong D, Liswood P, Todd W. Potential risks of accommodative padding of neuropathic ulcerations. Ostomy Wound Manage. 1995;41:44–49.
    1. Landsman A, Meaney D, Cargill R, Mararak E, Thibault L. High strain rate tissue deformation: A theory on the mechanical etiology of diabetic foot ulcerations. J Am Podiatr Med Assoc. 1995;85(10):519–526.
    1. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev. 2002;18:S64–S69. doi: 10.1002/dmrr.279.
    1. Chuck AW, Hailey D, Jacobs P, Perry DC. Cost effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. Int J Technol Assess Health Care. 2008;24(2):178–183.
    1. Chantelau E, Haage P. An audit of cushioned diabetic footwear: relation to patient compliance. Diabet Med. 1994;11(1):114–116. doi: 10.1111/j.1464-5491.1994.tb00240.x.
    1. Chantelau E, Breuer U, Leisch AC, Tanudjaja T, Reuter M. Outpatient treatment of unilateral diabetic foot ulcers with 'half shoes'. Diabet Med. 1993;10(3):267–270. doi: 10.1111/j.1464-5491.1993.tb00056.x.
    1. Cavanagh P, Morag E, Boulton A, Young M, Deffner K, Pammer S. The relationship of static foot structure to dynamic foot function. J Biomech. 1997;30(3):243–250. doi: 10.1016/S0021-9290(96)00136-4.
    1. Mueller M, Hastings M, Commean P, Smith K, Pilgram T, Robertson D. et al.Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36(7):1009–1017. doi: 10.1016/S0021-9290(03)00078-2.
    1. Glasoe W, Allen M, Ludewig P, Saltzman C. Dorsal mobility and first ray stiffness in patients with diabetes mellitus. Foot and Ankle International. 2004;25(8):550–555.
    1. Fernando D, Masson E, Veves A, Boulton A. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care. 1991;14(1):8–11. doi: 10.2337/diacare.14.1.8.
    1. Delbridge I, Perry P, Marr S, Arnold N, Yue D, Turtle J. et al.Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabet Med. 1988;5:333–337. doi: 10.1111/j.1464-5491.1988.tb01000.x.
    1. Burton J. Thick skin and stiff joints in insulin-dependent diabetes mellitus. Br J Dermatol. 1982;106:369–371. doi: 10.1111/j.1365-2133.1982.tb01739.x.
    1. Evans AM, Copper AW, Scharfbillig RW, Scutter SD, Williams MT. Reliability of the foot posture index and traditional measures of foot position. Journal of the American Podiatric Medical Association. 2003;93(3):203–213.
    1. Keenan A-M, Redmond AC, Horton M, Conaghan PG, Tennant A. The Foot Posture Index: Rasch analysis of a novel, foot-specific outcome measure. Arch Phys Med Rehabil. 2007;88(1):88–93. doi: 10.1016/j.apmr.2006.10.005.
    1. Scharfbillig R, Evans AM, Copper AW, Williams M, Scutter S, Iasiello H. et al.Criterion validation of four criteria of the foot posture index. Journal of the American Podiatric Medical Association. 2004;94(1):31–38.
    1. Kato H, Takada T, Kawamura T, Torii NHS. The reduction and redistribution of plantar pressures using foot orthoses in diabetic patients. Diabetes Research in Clinical Practice. 1996;31:115–118. doi: 10.1016/0168-8227(96)01214-4.
    1. Bevans J. Biomechanics and plantar ulcers in diabetes. Foot. 1992;2:166–172. doi: 10.1016/0958-2592(92)90067-Y.
    1. Mueller M, Diamond J, Delitto A, Sinacore D. Insensitivity limited joint mobility and plantar ulcers in patients with diabetes mellitus. Phys Ther. 1989;69(6):453–462.
    1. Kirby KA. Methods for determination of positional variations in the subtalar joint axis. Journal of the American Podiatric medical Association. 1987;77(5):228–234.
    1. Kirby KA. Subtalar joint axis location and rotational equilibrium theory of foot function. Journal of the American Podiatric Medical Association. 2001;91(9):465–487.
    1. Kirby KA. Biomechanics of the normal and abnormal foot. Journal of the American Podiatric Medical Association. 2000;90(1):30–34.
    1. Kirby KA. Rotational equilibrium across the subtalar joint axis. Journal of the American Podiatric Medical Association. 1989;79(1):1–14.
    1. Kirby KA. The medial heel skive technique. Improving pronation control in foot orthoses. Journal of the American Podiatric Medical Association. 1992;82(4):177–188.
    1. Root M, Orien W, Weed J. Clinical Biomechanics Volume II. Normal and abnormal function of the foot. Los Angeles, California, USA: Clinical Biomechanics Corporation; 1977.
    1. Valmassy R. Clinical Biomechanics of the Lower Extremity. St Louis: Mosby; 1996.
    1. Mueller M, Minor S, Diamond J, Blair V III. Relationship of foot deformity to ulcer location in patients with diabetes mellitus. Phys Ther. 1990;70(6):356–362.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa